Literature DB >> 22131117

Carcinoma of the head and neck in the HPV era.

Antonio Cardesa1, Alfons Nadal.   

Abstract

This review encompasses the most salient advances in the understanding of the biopathology of head and neck squamous-cell carcinoma (HNSCC) accomplished over the last decade, emphasizing the significant role played by high-risk HPV genotypes. This has led to a new and meaningful subdivision of conventional HNSCC in two main prognostic and therapeutic groups: 1) keratinizing HNSCC, mainly occurring in elderly men that are heavy smokers and drinkers, TP53 mutated and/or p53-positive, HPV16-negative, being associated with an aggressive course; and 2) non-keratinizing HNSCC, occurring in younger men between 40 and 60 years that are non-smokers and non-drinkers, HPV16- positive, p16-positive, and p53- negative, being associated with improved prognosis. The main risk factors are number of sexual partners, oral-genital sex, oral-anal sex, and marijuana use. Among the unusual variants of HNSCC, papillary and lymphoepithelial-like are mostly related to HPV-16 infection, whereas the spindle and acantholytic types are mainly associated with tobacco and alcohol. The basaloid, adenosquamous, and verrucous variants may be related to both types of risk factors. Spindle cell carcinoma has been shown to be a prototype of epithelial mesenchymal transition. The hallmark of the novel and aggressive entity "undifferentiated midline carcinoma" is the rearrangement of the Nuclear Protein in Testis (NUT) gene at t[15; 19]. In the HPV era we are proposing the Ljubljana Classification (LC) as the recommended system for grading precursor lesions in heavy cigarette smokers and alcohol drinkers and the dysplasia and SIN systems for grading intraepithelial precursor lesions related to the increasingly detected epidemic of HNSCC associated with high-risk HPV infections.

Entities:  

Mesh:

Year:  2011        PMID: 22131117

Source DB:  PubMed          Journal:  Acta Dermatovenerol Alp Pannonica Adriat        ISSN: 1318-4458


  23 in total

1.  Meta-signature of mutated genes in gallbladder cancer: evidence based high throughput screening assays.

Authors:  Kai Qu; Xing Zhang; Ruixia Cui; Chang Liu
Journal:  Ann Transl Med       Date:  2016-06

2.  Human papillomavirus status and gene expression profiles of oropharyngeal and oral cancers from European American and African American patients.

Authors:  Swati Tomar; Christian A Graves; Diego Altomare; Sangeeta Kowli; Susannah Kassler; Natalie Sutkowski; M Boyd Gillespie; Kim E Creek; Lucia Pirisi
Journal:  Head Neck       Date:  2015-06-15       Impact factor: 3.147

Review 3.  Updated overview of current biomarkers in head and neck carcinoma.

Authors:  Kiran Dahiya; Rakesh Dhankhar
Journal:  World J Methodol       Date:  2016-03-26

4.  Papillary variant of squamous cell carcinoma arising on the gingiva: 61 cases reported from within a larger series of gingival squamous cell carcinoma.

Authors:  Sarah G Fitzpatrick; Ashley N Neuman; Donald M Cohen; Indraneel Bhattacharyya
Journal:  Head Neck Pathol       Date:  2013-04-26

5.  PHF21B as a candidate tumor suppressor gene in head and neck squamous cell carcinomas.

Authors:  Fernanda Bernardi Bertonha; Mateus de Camargo Barros Filho; Hellen Kuasne; Patricia Pintor Dos Reis; Erika da Costa Prando; Juan José Augusto Moyano Muñoz; Martín Roffé; Glaucia Noeli Maroso Hajj; Luiz Paulo Kowalski; Claudia Aparecida Rainho; Silvia Regina Rogatto
Journal:  Mol Oncol       Date:  2014-10-13       Impact factor: 6.603

6.  Immunohistochemical expression levels of p53 and eIF4E markers in histologically negative surgical margins, and their association with the clinical outcome of patients with head and neck squamous cell carcinoma.

Authors:  Jagtar Singh; Rama Jayaraj; Siddhartha Baxi; Mariana Mileva; John Skinner; Navneet K Dhand; Mahiban Thomas
Journal:  Mol Clin Oncol       Date:  2015-12-01

7.  The prognostic role of claudins in head and neck squamous cell carcinomas.

Authors:  Györgyi A Nelhűbel; Boróka Károly; Balázs Szabó; Gábor Lotz; András Kiss; József Tóvári; István Kenessey
Journal:  Pathol Oncol Res       Date:  2013-07-12       Impact factor: 3.201

8.  Is there a patient population with squamous cell carcinoma of the head and neck region who might benefit from de-intensification of postoperative radiotherapy? : A monocentric retrospective analysis of a previously defined low-risk patient population treated with standard-of-care radiotherapy.

Authors:  Yonca Onbasi; Sebastian Lettmaier; Markus Hecht; Sabine Semrau; Heinrich Iro; Marco Kesting; Rainer Fietkau; Marlen Haderlein
Journal:  Strahlenther Onkol       Date:  2019-01-04       Impact factor: 3.621

9.  Prevalence of human papillomavirus in oral squamous cell carcinomas in northern Spain.

Authors:  Tania Rodríguez-Santamarta; Juan Pablo Rodrigo; Juana M García-Pedrero; Saúl Álvarez-Teijeiro; M Ángeles Villaronga; Laura Suárez-Fernández; Marta E Alvarez-Argüelles; Aurora Astudillo; Juan Carlos de Vicente
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-24       Impact factor: 2.503

10.  The dual pathway inhibitor rigosertib is effective in direct patient tumor xenografts of head and neck squamous cell carcinomas.

Authors:  Ryan T Anderson; Stephen B Keysar; Daniel W Bowles; Magdalena J Glogowska; David P Astling; J Jason Morton; Phuong Le; Adrian Umpierrez; Justin Eagles-Soukup; Gregory N Gan; Brian W Vogler; Daniel Sehrt; Sarah M Takimoto; Dara L Aisner; Francois Wilhelm; Barbara A Frederick; Marileila Varella-Garcia; Aik-Choon Tan; Antonio Jimeno
Journal:  Mol Cancer Ther       Date:  2013-07-19       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.